Artashez Pashinian

424 total citations
10 papers, 320 citations indexed

About

Artashez Pashinian is a scholar working on Psychiatry and Mental health, Clinical Psychology and Biological Psychiatry. According to data from OpenAlex, Artashez Pashinian has authored 10 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Clinical Psychology and 4 papers in Biological Psychiatry. Recurrent topics in Artashez Pashinian's work include Schizophrenia research and treatment (6 papers), Obsessive-Compulsive Spectrum Disorders (4 papers) and Tryptophan and brain disorders (4 papers). Artashez Pashinian is often cited by papers focused on Schizophrenia research and treatment (6 papers), Obsessive-Compulsive Spectrum Disorders (4 papers) and Tryptophan and brain disorders (4 papers). Artashez Pashinian collaborates with scholars based in Israel and United States. Artashez Pashinian's co-authors include Michael Poyurovsky, Camil Fuchs, Sarit Faragian, Ronit Weizman, Abraham Weizman, Rachel Maayan, Irit Gil‐Ad, Joseph Bergman, Yuly Bersudsky and Vladimir Lerner and has published in prestigious journals such as Psychopharmacology, The Journal of Nervous and Mental Disease and Psychiatry Research.

In The Last Decade

Artashez Pashinian

10 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Artashez Pashinian Israel 9 161 116 64 62 60 10 320
Karolina Furczyk Germany 5 88 0.5× 61 0.5× 86 1.3× 35 0.6× 50 0.8× 7 308
Yuen Mei See Singapore 8 192 1.2× 42 0.4× 102 1.6× 102 1.6× 34 0.6× 17 369
R.D. Jewart United States 7 178 1.1× 35 0.3× 90 1.4× 63 1.0× 53 0.9× 10 346
Kaija Huuhka Finland 12 165 1.0× 57 0.5× 41 0.6× 154 2.5× 18 0.3× 15 334
P. Danjou France 11 121 0.8× 34 0.3× 133 2.1× 60 1.0× 52 0.9× 25 404
Huma Ikram Pakistan 12 51 0.3× 107 0.9× 36 0.6× 20 0.3× 63 1.1× 38 416
Bastian Wollweber Germany 7 59 0.4× 64 0.6× 85 1.3× 66 1.1× 10 0.2× 9 313
Bartosz Wasilewski Poland 4 46 0.3× 39 0.3× 29 0.5× 53 0.9× 70 1.2× 11 318
H. Silva Chile 4 109 0.7× 36 0.3× 55 0.9× 16 0.3× 66 1.1× 6 352
Marta Silva United Kingdom 11 132 0.8× 42 0.4× 138 2.2× 23 0.4× 46 0.8× 18 373

Countries citing papers authored by Artashez Pashinian

Since Specialization
Citations

This map shows the geographic impact of Artashez Pashinian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Artashez Pashinian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Artashez Pashinian more than expected).

Fields of papers citing papers by Artashez Pashinian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Artashez Pashinian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Artashez Pashinian. The network helps show where Artashez Pashinian may publish in the future.

Co-authorship network of co-authors of Artashez Pashinian

This figure shows the co-authorship network connecting the top 25 collaborators of Artashez Pashinian. A scholar is included among the top collaborators of Artashez Pashinian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Artashez Pashinian. Artashez Pashinian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Miodownik, Chanoch, Vladimir Lerner, Artashez Pashinian, et al.. (2019). Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study. Clinical Neuropharmacology. 42(4). 117–122. 45 indexed citations
2.
Pashinian, Artashez, et al.. (2014). The beneficial effect of escitalopram on obsessive–compulsive-related musical hallucinations in elderly patients with hearing impairment. International Clinical Psychopharmacology. 29(5). 263–265. 7 indexed citations
3.
Poyurovsky, Michael, et al.. (2014). Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia. International Clinical Psychopharmacology. 29(5). 296–298. 12 indexed citations
4.
Maayan, Rachel, Irit Gil‐Ad, Artashez Pashinian, et al.. (2013). The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients. Psychopharmacology. 230(1). 23–27. 17 indexed citations
5.
Poyurovsky, Michael, et al.. (2012). Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination. Psychopharmacology. 226(3). 615–622. 59 indexed citations
6.
Poyurovsky, Michael, Sarit Faragian, Camil Fuchs, & Artashez Pashinian. (2009). Effect of the selective norepinephrine reuptake inhibitor reboxetine on cognitive dysfunction in schizophrenia patients: an add-on, double-blind placebo-controlled study.. PubMed. 46(3). 213–20. 18 indexed citations
7.
Poyurovsky, Michael, et al.. (2008). Clinical characteristics of schizotypal-related obsessive-compulsive disorder. Psychiatry Research. 159(1-2). 254–258. 46 indexed citations
8.
Poyurovsky, Michael, Camil Fuchs, Artashez Pashinian, et al.. (2007). Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study. Psychopharmacology. 192(3). 441–448. 63 indexed citations
9.
Poyurovsky, Michael, et al.. (2007). Awareness of Illness and Insight Into Obsessive-Compulsive Symptoms in Schizophrenia Patients With Obsessive-Compulsive Disorder. The Journal of Nervous and Mental Disease. 195(9). 765–768. 22 indexed citations
10.
Poyurovsky, Michael, Camil Fuchs, Sarit Faragian, et al.. (2006). Preferential Aggregation of Obsessive—Compulsive Spectrum Disorders in Schizophrenia Patients with Obsessive—Compulsive Disorder. The Canadian Journal of Psychiatry. 51(12). 746–754. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karolina Furczyk Breakdown of academic impact, for papers by Yuen Mei See Breakdown of academic impact, for papers by R.D. Jewart Breakdown of academic impact, for papers by Kaija Huuhka Breakdown of academic impact, for papers by P. Danjou Breakdown of academic impact, for papers by Huma Ikram Breakdown of academic impact, for papers by Bastian Wollweber Breakdown of academic impact, for papers by Bartosz Wasilewski Breakdown of academic impact, for papers by H. Silva Breakdown of academic impact, for papers by Marta Silva
Rankless by CCL
2026